Expand AVTX Menu
AVTX MENU

AVTX Latest Press Releases

-- June 26, 2026 --

Avalo Therapeutics to Join the Russell 2000 and Russell 3000 Indexes Globe Newswire 7:00 AM

-- June 23, 2026 --

Avalo Therapeutics Appoints Ron Philip to Board of Directors Globe Newswire 7:00 AM

-- June 16, 2026 --

Avalo Therapeutics Expands Pipeline with AVTX-010, a Long-Acting Next-Generation Anti-IL-1 Antibody Globe Newswire 7:00 AM

-- May 22, 2026 --

Avalo Therapeutics Announces Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:01 PM

-- May 13, 2026 --

Avalo Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Updates Globe Newswire 7:00 AM

-- May 5, 2026 --

Avalo Therapeutics Announces Pricing of $375 Million Public Offering Globe Newswire 11:33 PM
Avalo Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants Globe Newswire 4:05 PM
Avalo Therapeutics Achieves Positive Topline Results in Phase 2 LOTUS Trial of Abdakibart (AVTX-009) in Moderate to Severe Hidradenitis Suppurativa Globe Newswire 4:01 PM

-- April 28, 2026 --

Avalo Therapeutics Purchases Optional Milestone Buyout Globe Newswire 7:00 AM

-- March 23, 2026 --

Avalo Therapeutics Reports 2025 Financial Results and Recent Business Updates Globe Newswire 7:00 AM

-- February 24, 2026 --

Avalo Therapeutics to Participate in Upcoming Investor Conferences Globe Newswire 7:00 AM

-- February 18, 2026 --

Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- February 4, 2026 --

Avalo Therapeutics to Participate in Upcoming Investor Conferences Globe Newswire 7:00 AM
Market Data Delayed 15 Minutes